Exact Mass: 333.1974

Exact Mass Matches: 333.1974

Found 117 metabolites which its exact mass value is equals to given mass value 333.1974, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

alpha-Eucaine

alpha-Eucaine

C19H27NO4 (333.194)


   

Nolomirole

6-(Methylamino)-2-[(2-methylpropanoyl)oxy]-5,6,7,8-tetrahydronaphthalen-1-yl 2-methylpropanoic acid

C19H27NO4 (333.194)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

6-Ac-Cyclizidine

6-Ac-Cyclizidine

C19H27NO4 (333.194)


   

glaciapyrrole A

glaciapyrrole A

C19H27NO4 (333.194)


   

4-(3,4-dimethoxyphenyl)-4-<2-(acetylmethyloamino)ethyl>cyclohexanone

4-(3,4-dimethoxyphenyl)-4-<2-(acetylmethyloamino)ethyl>cyclohexanone

C19H27NO4 (333.194)


   

MCULE-9157036760

MCULE-9157036760

C19H27NO4 (333.194)


   

N-[trans-4-(2-hydroxy-1-methylethyl)cyclohexanecarbonyl]-D-phenylalanine

N-[trans-4-(2-hydroxy-1-methylethyl)cyclohexanecarbonyl]-D-phenylalanine

C19H27NO4 (333.194)


   

(-)-alpha-roemehybrine

(-)-alpha-roemehybrine

C19H27NO4 (333.194)


   

3,4-Dimethoxy-benzoic acid 8-isopropyl-8-aza-bicyclo[3.2.1]oct-3-yl ester

3,4-Dimethoxy-benzoic acid 8-isopropyl-8-aza-bicyclo[3.2.1]oct-3-yl ester

C19H27NO4 (333.194)


   

N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexanecarbonyl]-D-phenylalanine

N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexanecarbonyl]-D-phenylalanine

C19H27NO4 (333.194)


   

Oreobeiline

Oreobeiline

C19H27NO4 (333.194)


   

acetyllycoposerramine-U

acetyllycoposerramine-U

C19H27NO4 (333.194)


   

7-hydroxyl benzastatin D

7-hydroxyl benzastatin D

C19H27NO4 (333.194)


   

2,3,5,6-Tetrahydro,Me ether-4-[2-(Acetylmethylamino)ethyl]-4-(4-hydroxy-3-methoxyphenyl)-2,4-cyclohexadien-1-one

2,3,5,6-Tetrahydro,Me ether-4-[2-(Acetylmethylamino)ethyl]-4-(4-hydroxy-3-methoxyphenyl)-2,4-cyclohexadien-1-one

C19H27NO4 (333.194)


   

(2R)-2-[N-(trans-4-isopropylcyclohexylcarbonyl)amino]-3-(4-hydroxyphenyl)-propionic acid

(2R)-2-[N-(trans-4-isopropylcyclohexylcarbonyl)amino]-3-(4-hydroxyphenyl)-propionic acid

C19H27NO4 (333.194)


   

ACMC-20m4ua

ACMC-20m4ua

C14H27N3O6 (333.19)


   

Leu Thr Ser

Leu Thr Ser

C14H27N3O6 (333.19)


   

Ser Leu Thr

Ser Leu Thr

C14H27N3O6 (333.19)


   

Thr Leu Ser

Thr Leu Ser

C14H27N3O6 (333.19)


   

Leu Ser Thr

Leu Ser Thr

C14H27N3O6 (333.19)


   

Thr Thr Ile

Thr Thr Ile

C14H27N3O6 (333.19)


   

Ser Thr Leu

Ser Thr Leu

C14H27N3O6 (333.19)


   

Thr Ser Leu

Thr Ser Leu

C14H27N3O6 (333.19)


   

Thr Ile Thr

Thr Ile Thr

C14H27N3O6 (333.19)


   

Ile Thr Thr

Ile Thr Thr

C14H27N3O6 (333.19)


   

Thr Thr Leu

Thr Thr Leu

C14H27N3O6 (333.19)


   

Thr Leu Thr

Thr Leu Thr

C14H27N3O6 (333.19)


   

Leu Thr Thr

Leu Thr Thr

C14H27N3O6 (333.19)


   

Hydroxytetrabenazine

Hydroxytetrabenazine

C19H27NO4 (333.194)


   

NA 19:6;O3

N-(8-methyl-nonanoyl)-2,3-(Z)-dehydrotyrosine

C19H27NO4 (333.194)


   
   

Drotebanol

Oxymethebanol

C19H27NO4 (333.194)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-ISOPROPYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-ISOPROPYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C19H27NO4 (333.194)


   

Saxagliptin hydrate

Saxagliptin hydrate

C18H27N3O3 (333.2052)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

2-acetamido-n-(e-aminocaproyl)-2-deoxy-beta-d-glucopyranosylamine

2-acetamido-n-(e-aminocaproyl)-2-deoxy-beta-d-glucopyranosylamine

C14H27N3O6 (333.19)


   

(2S,3R)-1-Benzyl 3-tert-butyl 2-methylpiperidine-1,3-dicarboxylate

(2S,3R)-1-Benzyl 3-tert-butyl 2-methylpiperidine-1,3-dicarboxylate

C19H27NO4 (333.194)


   

TERT-BUTYL4-(2-METHYL-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL4-(2-METHYL-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE

C18H27N3O3 (333.2052)


   

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-METHYLBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-METHYLBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

C19H27NO4 (333.194)


   

(2,6-DIOXO-3,6-DIHYDROPYRIMIDIN-1(2H)-YL)ACETICACID

(2,6-DIOXO-3,6-DIHYDROPYRIMIDIN-1(2H)-YL)ACETICACID

C18H27N3O3 (333.2052)


   

Ethyl cis-N-Boc-3-phenylpiperidine-4-carboxylate

Ethyl cis-N-Boc-3-phenylpiperidine-4-carboxylate

C19H27NO4 (333.194)


   

1-Benzyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indole

1-Benzyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indole

C21H24BNO2 (333.19)


   

Saxagliptin Impurity 15

Saxagliptin Impurity 15

C18H27N3O3 (333.2052)


   

4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide

4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide

C18H27N3O3 (333.2052)


   

BENZYL (+/-)-TRANS-N-BOC-4-METHYL-PIPERIDINE-2-CARBOXYLATE

BENZYL (+/-)-TRANS-N-BOC-4-METHYL-PIPERIDINE-2-CARBOXYLATE

C19H27NO4 (333.194)


   

1-Benzyl 3-ethyl 3-isopropyl-1,3-piperidinedicarboxylate

1-Benzyl 3-ethyl 3-isopropyl-1,3-piperidinedicarboxylate

C19H27NO4 (333.194)


   

benzhydrylboronic acid,4-propan-2-ylpyridine

benzhydrylboronic acid,4-propan-2-ylpyridine

C21H24BNO2 (333.19)


   
   

(1S,9S,10S,13R)-3,4-Dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-10,13-diol

(1S,9S,10S,13R)-3,4-Dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-10,13-diol

C19H27NO4 (333.194)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

(5S,6E,8Z,11Z,14Z,16E,18R)-5,18-dihydroxyicosa-6,8,11,14,16-pentaenoate

(5S,6E,8Z,11Z,14Z,16E,18R)-5,18-dihydroxyicosa-6,8,11,14,16-pentaenoate

C20H29O4- (333.2066)


   

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oate

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oate

C20H29O4- (333.2066)


   

(5Z,13E,15S)-15-hydroxy-11-oxoprosta-5,9,13-trien-1-oate

(5Z,13E,15S)-15-hydroxy-11-oxoprosta-5,9,13-trien-1-oate

C20H29O4- (333.2066)


   

15-dehydroprostaglandin B1

15-dehydroprostaglandin B1

C20H29O4- (333.2066)


   

(7R,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate

(7R,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate

C20H29O4- (333.2066)


   

(7S,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate

(7S,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate

C20H29O4- (333.2066)


   

(7E,9E,11Z,13E,15R)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate

(7E,9E,11Z,13E,15R)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate

C20H29O4- (333.2066)


   

(7E,9E,11Z,13E,15S)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate

(7E,9E,11Z,13E,15S)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate

C20H29O4- (333.2066)


   

Ent-6alpha, 7alpha-dihydroxykaur-16-en-19-oate

Ent-6alpha, 7alpha-dihydroxykaur-16-en-19-oate

C20H29O4- (333.2066)


   

7-[[(3R,4R)-3-(butylsulfanylmethyl)-4-methylpyrrolidin-1-yl]methyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine

7-[[(3R,4R)-3-(butylsulfanylmethyl)-4-methylpyrrolidin-1-yl]methyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine

C17H27N5S (333.1987)


   

(5S,18S)-dihydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate

(5S,18S)-dihydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate

C20H29O4- (333.2066)


   

2,2-dimethyl-N-[[2-(4-methyl-1-piperidinyl)anilino]-sulfanylidenemethyl]propanamide

2,2-dimethyl-N-[[2-(4-methyl-1-piperidinyl)anilino]-sulfanylidenemethyl]propanamide

C18H27N3OS (333.1875)


   

5,20-diHEPE(1-)

5,20-diHEPE(1-)

C20H29O4- (333.2066)


An icosanoid anion that is the conjugate base of 5,20-di-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

N-(3,3-dimethylbutyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine

N-(3,3-dimethylbutyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine

C20H23N5 (333.1953)


   

12(S)-HpEPE(1-)

12(S)-HpEPE(1-)

C20H29O4- (333.2066)


A 12-HPEPE anion that is the conjugate base of 12(S)-HpEPE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

15-dehydroprostaglandin A1(1-)

15-dehydroprostaglandin A1(1-)

C20H29O4- (333.2066)


A prostaglandin carboxylic acid anion that is the conjugate base of 15-dehydro-prostaglandin A1, obtained by deprotonation of the carboxy group.; major species at pH 7.3.

   

12-Hpepe(1-)

12-Hpepe(1-)

C20H29O4- (333.2066)


A polyunsaturated fatty acid anion that is the conjugate base of 12-HPEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Tert-butyl 2-[3-(mesitylamino)-1-methyl-3-oxopropylidene]hydrazinecarboxylate

Tert-butyl 2-[3-(mesitylamino)-1-methyl-3-oxopropylidene]hydrazinecarboxylate

C18H27N3O3 (333.2052)


   

12-oxo-Leukotriene B4

12-oxo-Leukotriene B4

C20H29O4- (333.2066)


   

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,8(12),13-trien-1-oate

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,8(12),13-trien-1-oate

C20H29O4- (333.2066)


   

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,11,13-trien-1-oate

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,11,13-trien-1-oate

C20H29O4- (333.2066)


   
   

(5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate

(5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate

C20H29O4- (333.2066)


   

(5Z,8R,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate

(5Z,8R,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate

C20H29O4- (333.2066)


   

(5Z,12E,15S)-15-hydroxy-11-oxoprosta-5,9,12-trien-1-oate

(5Z,12E,15S)-15-hydroxy-11-oxoprosta-5,9,12-trien-1-oate

C20H29O4- (333.2066)


   

(5S,6E,8E,10E,14Z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoate

(5S,6E,8E,10E,14Z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoate

C20H29O4- (333.2066)


   

Ile-Thr-Thr

Ile-Thr-Thr

C14H27N3O6 (333.19)


   

Thr-Thr-Ile

Thr-Thr-Ile

C14H27N3O6 (333.19)


   

N-[(2R)-1-(3,5-dimethylphenoxy)propan-2-yl]-6-(2-fluoropropan-2-yl)-1,3,5-triazine-2,4-diamine

N-[(2R)-1-(3,5-dimethylphenoxy)propan-2-yl]-6-(2-fluoropropan-2-yl)-1,3,5-triazine-2,4-diamine

C17H24FN5O (333.1965)


   

Leu-Thr-Thr

Leu-Thr-Thr

C14H27N3O6 (333.19)


   

Thr-Ile-Thr

Thr-Ile-Thr

C14H27N3O6 (333.19)


   

Thr-Leu-Thr

Thr-Leu-Thr

C14H27N3O6 (333.19)


   

Thr-Thr-Leu

Thr-Thr-Leu

C14H27N3O6 (333.19)


   
   

N-[(2S)-1-(3,5-dimethylphenoxy)propan-2-yl]-6-(2-fluoropropan-2-yl)-1,3,5-triazine-2,4-diamine

N-[(2S)-1-(3,5-dimethylphenoxy)propan-2-yl]-6-(2-fluoropropan-2-yl)-1,3,5-triazine-2,4-diamine

C17H24FN5O (333.1965)


   

(5S,6Z,8E,10E,12R,14Z,17Z)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoate

(5S,6Z,8E,10E,12R,14Z,17Z)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoate

C20H29O4- (333.2066)


   

5(S)-HpEPE(1-)

5(S)-HpEPE(1-)

C20H29O4- (333.2066)


   

(3R,9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydecanoate

(3R,9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydecanoate

C16H29O7- (333.1913)


   

14-oxo-15-hydroxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate

14-oxo-15-hydroxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate

C20H29O4- (333.2066)


   

(15S)-hydroperoxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate

(15S)-hydroperoxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate

C20H29O4- (333.2066)


   

(3R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydecanoate

(3R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydecanoate

C16H29O7- (333.1913)


   

prostaglandin J2(1-)

prostaglandin J2(1-)

C20H29O4 (333.2066)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin J2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(18S)-resolvin E2(1-)

(18S)-resolvin E2(1-)

C20H29O4 (333.2066)


An icosanoid anion that is the conjugate base of (18S)-resolvin E2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin B2(1-)

prostaglandin B2(1-)

C20H29O4 (333.2066)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin B2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin C2(1-)

prostaglandin C2(1-)

C20H29O4 (333.2066)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin C2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

leukotriene B5(1-)

leukotriene B5(1-)

C20H29O4 (333.2066)


An icosanoid anion that is the conjugate base of leukotriene B5, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

bhos#16(1-)

bhos#16(1-)

C16H29O7 (333.1913)


Conjugate base of bhos#16

   

bhas#16(1-)

bhas#16(1-)

C16H29O7 (333.1913)


Conjugate base of bhas#16

   

resolvin E2(1-)

resolvin E2(1-)

C20H29O4 (333.2066)


A polyunsaturated fatty acid anion that is the conjugate base of resolvin E2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin A2(1-)

prostaglandin A2(1-)

C20H29O4 (333.2066)


A prostaglandin carboxylic acid anion resulting from the removal of the proton from the carboxy group of prostaglandin A2.

   

NA-Taurine 14:1(9Z)

NA-Taurine 14:1(9Z)

C16H31NO4S (333.1974)


   

6-hydroxy-6-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)hexa-2,4-dien-1-one

6-hydroxy-6-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)hexa-2,4-dien-1-one

C19H27NO4 (333.194)


   

2-[(1-hydroxy-2-methylbutylidene)amino]-n-(2-phenylethyl)pentanediimidic acid

2-[(1-hydroxy-2-methylbutylidene)amino]-n-(2-phenylethyl)pentanediimidic acid

C18H27N3O3 (333.2052)


   

(2z)-2-[(1-hydroxydecylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

(2z)-2-[(1-hydroxydecylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C19H27NO4 (333.194)


   

(1s,4s,5s,6s,9s)-6-methyl-2,8-dioxo-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecan-5-yl acetate

(1s,4s,5s,6s,9s)-6-methyl-2,8-dioxo-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecan-5-yl acetate

C19H27NO4 (333.194)


   

3-{[(1r,2r,4as,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl](hydroxy)methylidene}-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

3-{[(1r,2r,4as,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl](hydroxy)methylidene}-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

C19H27NO4 (333.194)


   

(2s)-2-{[(2r)-1-hydroxy-2-methylbutylidene]amino}-n-(2-phenylethyl)pentanediimidic acid

(2s)-2-{[(2r)-1-hydroxy-2-methylbutylidene]amino}-n-(2-phenylethyl)pentanediimidic acid

C18H27N3O3 (333.2052)


   

3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

C19H27NO4 (333.194)


   

(2z,4e)-6-hydroxy-6-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)hexa-2,4-dien-1-one

(2z,4e)-6-hydroxy-6-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)hexa-2,4-dien-1-one

C19H27NO4 (333.194)


   

(1r,3r,4r,4's)-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

(1r,3r,4r,4's)-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

C19H27NO4 (333.194)


   

n-{2-[1-(3,4-dimethoxyphenyl)-4-oxocyclohexyl]ethyl}-n-methylacetamide

n-{2-[1-(3,4-dimethoxyphenyl)-4-oxocyclohexyl]ethyl}-n-methylacetamide

C19H27NO4 (333.194)


   

4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-5,12-diol

4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-5,12-diol

C19H27NO4 (333.194)


   

6,7,11-trihydroxy-3,7,11-trimethyl-1-(1h-pyrrol-2-yl)dodeca-2,4,9-trien-1-one

6,7,11-trihydroxy-3,7,11-trimethyl-1-(1h-pyrrol-2-yl)dodeca-2,4,9-trien-1-one

C19H27NO4 (333.194)


   

3-[hydroxy(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)methylidene]-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

3-[hydroxy(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)methylidene]-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

C19H27NO4 (333.194)


   

2-[(1-hydroxydecylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

2-[(1-hydroxydecylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C19H27NO4 (333.194)


   

(2z)-2-[(1-hydroxy-8-methylnonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

(2z)-2-[(1-hydroxy-8-methylnonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C19H27NO4 (333.194)


   

(2z,4e,9e)-6,7,11-trihydroxy-3,7,11-trimethyl-1-(1h-pyrrol-2-yl)dodeca-2,4,9-trien-1-one

(2z,4e,9e)-6,7,11-trihydroxy-3,7,11-trimethyl-1-(1h-pyrrol-2-yl)dodeca-2,4,9-trien-1-one

C19H27NO4 (333.194)


   

2-[(1-hydroxy-8-methylnonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

2-[(1-hydroxy-8-methylnonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C19H27NO4 (333.194)